Announcement on Appointment of Vice President
Filed with SSE · · 2 pages · Chinese
Joincare Pharmaceutical Group Industry Co., Ltd. on 6ix
Earlier from Joincare Pharmaceutical Group Industry
- Indicative Announcement on Inclusion of Rekonkitta Monoclonal Antibody Injection into the Priority Review and Approval Program
- Announcement on Subsidiary Obtaining PIC/S GMP Certification
- Indicative Announcement on Acceptance of Marketing Authorization Application for Laikangchita Monoclonal Antibody Injection
- Announcement on Obtaining Drug Registration Certificate for Maribavir Capsules (Yilikang®)
- Announcement on the Inclusion of the Company’s Product in the National Medical Insurance Catalog
Later from Joincare Pharmaceutical Group Industry
- Announcement on Resolutions of the 16th Meeting of the 9th Board of Directors
- Indicative Announcement on Extension of the Six-month Duration of Phase I of the Medium-and Long-term Business Partner Shareholding Plan
- Announcement on Progress in Holding Subsidiary Livzon Group Planning to Publicly Acquire Equity of Vietnam IMP Company
- Announcement on Obtaining Notice of Approval for Drug Clinical Trials of Brexpiprazole Microspheres for Injection
- Announcement on Company Credit Financing and Providing Financing Guarantee for Subsidiaries
Follow Joincare Pharmaceutical Group Industry into a list and get an email when it puts out news.
Follow Joincare Pharmaceutical Group Industry